Wall Street brokerages expect Limoneira (NASDAQ:LMNR) to post earnings of ($0.19) per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Limoneira’s earnings, with the highest EPS estimate coming in at ($0.18) and the lowest estimate coming in at ($0.20). Limoneira also posted earnings per share of ($0.19) in the same quarter last year. The company is expected to report its next earnings results on Monday, January 14th.
On average, analysts expect that Limoneira will report full-year earnings of $0.66 per share for the current fiscal year, with EPS estimates ranging from $0.65 to $0.67. For the next year, analysts forecast that the business will post earnings of $0.93 per share, with EPS estimates ranging from $0.91 to $0.95. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that follow Limoneira.
Limoneira (NASDAQ:LMNR) last announced its quarterly earnings data on Monday, September 10th. The company reported $0.50 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.55 by ($0.05). The firm had revenue of $39.95 million during the quarter, compared to analysts’ expectations of $37.68 million. Limoneira had a return on equity of 6.46% and a net margin of 15.91%.
LMNR stock traded down $0.96 during trading on Tuesday, hitting $22.90. 69,300 shares of the company’s stock traded hands, compared to its average volume of 83,665. The firm has a market capitalization of $426.54 million, a P/E ratio of 54.52, a price-to-earnings-growth ratio of 1.74 and a beta of 0.85. The company has a quick ratio of 0.81, a current ratio of 0.99 and a debt-to-equity ratio of 0.31. Limoneira has a 52 week low of $19.62 and a 52 week high of $33.42.
In related news, Director John W.H. Merriman sold 2,200 shares of the business’s stock in a transaction that occurred on Thursday, September 20th. The stock was sold at an average price of $28.01, for a total transaction of $61,622.00. Following the transaction, the director now directly owns 1,218 shares of the company’s stock, valued at approximately $34,116.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.50% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Atlas Capital Advisors LLC bought a new position in shares of Limoneira in the third quarter worth $108,000. Bank of Montreal Can lifted its holdings in shares of Limoneira by 6,740.2% during the third quarter. Bank of Montreal Can now owns 5,951 shares of the company’s stock valued at $155,000 after purchasing an additional 5,864 shares during the last quarter. MetLife Investment Advisors LLC lifted its stake in Limoneira by 56.1% in the 3rd quarter. MetLife Investment Advisors LLC now owns 9,690 shares of the company’s stock worth $253,000 after acquiring an additional 3,481 shares in the last quarter. Trexquant Investment LP acquired a new position in Limoneira in the 2nd quarter worth about $285,000. Finally, Royal Bank of Canada increased its position in Limoneira by 62.0% in the 1st quarter. Royal Bank of Canada now owns 13,333 shares of the company’s stock worth $316,000 after purchasing an additional 5,103 shares during the last quarter. Hedge funds and other institutional investors own 50.29% of the company’s stock.
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through six segments: Fresh Lemons, Lemon Packing, Avocados, Other Agribusiness, Rental Operations, and Real Estate Development. The Fresh Lemons segment markets and sells lemons directly to food service, wholesale, and retail customers.
Featured Article: Investing in Growth Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.